Clinical Trial Update: Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing ReJoinTM to sodium hyaluronate for knee osteoarthritis and articular cartilage defects is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Defect of Articular Cartilage
• Knee Osteoarthritis

Drugs mentioned

• ReJoinTM
• Sodium hyaluronate injection (sodium hyaluronate)

Snippet

Sponsor: Shanghai AbelZeta Ltd. | Conditions: Defect of Articular Cartilage, Knee Osteoarthritis | Phase 2 | Status: UNKNOWN